The spread of transgene expression at the site of gene construct injection
- 20 March 2001
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 24 (4), 488-495
- https://doi.org/10.1002/mus.1031
Abstract
Seven 2-day-old golden retriever pups were given focal intramuscular injections of a first generation adenovirus-dystrophin minigene construct and adenovirus-beta-galactosidase construct as a 2:1 mixture into the left anterior tibial muscle. The spread of transgene expression within the anterior tibial muscle was compared with the spread of methylene blue dye after identical injection into the contralateral muscle. Transgene expression 5-7 days after intramuscular injection was shown to extend between 5.8 and 11.6 mm along the biopsied muscle length (range of biopsy lengths 11.1-12.2 mm). The level of transgene expression at 2-2.5-mm intervals from the site of injection was significantly related to the distance from the site of injection (dystrophin, P = 0.009; beta-galactosidase, P = 0.015). The spread of methylene blue dye within the anterior tibial muscle < or =24 h after identical intramuscular injection demonstrated a similar pattern to the transgene expression, with dye staining measured between 5.5 and 8.5 mm along the muscle sample length (range of biopsy lengths 5.6-15.6 mm). The greatest transgene expression and dye staining was measured 2-2.5 mm proximal to the site of injection with a maximum of 23% of muscle fibers expressing the dystrophin transgene, 95.2% expressing the beta-galactosidase transgene, and 98% of the tissue section stained with methylene blue dye. These results suggest transgene expression after focal intramuscular injection is relatively localized around the site of injection. Further research is required to develop techniques that will provide transgene expression throughout the length and breadth of a muscle.Keywords
Funding Information
- Muscular Dystrophy Associations, USA and Canada
- Neuromuscular Foundation of Western Australia
- Medical Research Council of Canada
- National Research Council of Canada
- Deutsche Forschungsgemeinschaft
- Grimmke-Stiftung, Germany
This publication has 11 references indexed in Scilit:
- Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vectorNature Medicine, 1999
- High-Level Dystrophin Expression after Adenovirus-Mediated Dystrophin Minigene Transfer to Skeletal Muscle of Dystrophic Dogs: Prolongation of Expression with ImmunosuppressionHuman Gene Therapy, 1998
- Direct dystrophin and reporter gene transfer into dog muscle in vivoMuscle & Nerve, 1998
- Persistence in muscle of an adenoviral vector that lacks all viral genesProceedings of the National Academy of Sciences, 1997
- Dystrophin Expression in Muscles of mdx Mice After Adenovirus-MediatedIn VivoGene TransferHuman Gene Therapy, 1996
- Emergence of Early Region 1-Containing Replication-Competent Adenovirus in Stocks of Replication-Defective Adenovirus Recombinants (ΔE1 + ΔE3) During Multiple Passages in 293 CellsHuman Gene Therapy, 1994
- Expression of a recombinant dystrophin in mdx mice using adenovirus vectorNeuromuscular Disorders, 1994
- Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx miceNature, 1993
- An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophyGenomics, 1992
- Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsNature, 1991